Compare STVN & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STVN | SHC |
|---|---|---|
| Founded | 1949 | 2015 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2021 | 2020 |
| Metric | STVN | SHC |
|---|---|---|
| Price | $16.80 | $15.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $25.67 | $20.33 |
| AVG Volume (30 Days) | 597.9K | ★ 2.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $9.67 | $7.51 |
| Revenue Next Year | $9.99 | $6.00 |
| P/E Ratio | ★ $27.15 | $57.11 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $12.89 | $10.80 |
| 52 Week High | $28.00 | $19.85 |
| Indicator | STVN | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 69.76 | 50.83 |
| Support Level | $13.58 | $15.18 |
| Resistance Level | $17.19 | $16.55 |
| Average True Range (ATR) | 0.74 | 0.41 |
| MACD | 0.23 | -0.03 |
| Stochastic Oscillator | 88.03 | 20.92 |
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.